texas oncology more breakthroughs. more victories

Share:

 
 

Texas Oncology–McKinney Celebrates Five Years of Providing Radiation Therapy Services

August 29, 2019

In April 2019, Debra Campbell was the first patient at Texas Oncology–McKinney to participate in a powerful form of radiation therapy, called high dose rate (HDR) brachytherapy, which offers one-millimeter accuracy, minimizing damage to healthy tissue surrounding the cancer. 

The treatment now available in Debra’s community not only minimized her travel time but also shortened her treatment time from weeks to just five days.

Debra is one of the thousands of patients whose life has been positively impacted by the leading-edge radiation therapy treatment options available at Texas Oncology–McKinney.

I was encouraged by the opportunity to take part in an exciting new offering.” Debra Campbell
Breast Cancer Patient 

Like Debra, approximately half of all cancer patients undergo a type of radiation therapy as part of their treatment.

Because of the frequent need of radiation treatments, the importance of providing this technology locally was evident.

That’s why Texas Oncology expanded its treatment capabilities five years ago to offer radiation therapy at the McKinney location

Since 2014, more than 1,400 Texas Oncology–McKinney patients have received radiation therapy close to home and near their critical support systems. Over 20 patients have been treated with HDR brachytherapy.

HDR brachytherapy is one of several radiation modalities offered in McKinney. Other options include Computed Tomography (CT), Intensity modulated radiation therapy (IMRT), and Stereotactic Body Radiotherapy (SBRT).

The addition of radiation therapy not only offers our patients the convenience of having their medical team under one roof, but also the comfort of staying close to home, work, and important support networks throughout treatment,” Anand Shivnani, M.D.
Radiation Oncologist at Texas Oncology–McKinney.

Over the past five years, Texas Oncology–McKinney physicians and patients have seen firsthand the importance of bringing new and innovative treatment and will continue to deliver on their promise to do so in the years to come.


For upcoming webinars visit www.TexasOncologyFoundation.org